Rovin Capital UT ADV raised its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 22.2% during the 2nd quarter, Holdings Channel.com reports. The firm owned 2,740 shares of the conglomerate’s stock after acquiring an additional 497 shares during the period. Rovin Capital UT ADV’s holdings in Danaher were worth $541,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Red Tortoise LLC boosted its position in Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Ramirez Asset Management Inc. purchased a new stake in shares of Danaher in the second quarter valued at approximately $40,000. Costello Asset Management INC purchased a new position in shares of Danaher during the 1st quarter valued at approximately $41,000. Mowery & Schoenfeld Wealth Management LLC lifted its position in shares of Danaher by 53.8% during the 1st quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock valued at $42,000 after buying an additional 71 shares in the last quarter. Finally, Iron Horse Wealth Management LLC acquired a new stake in Danaher in the 1st quarter valued at $50,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Activity at Danaher
In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is owned by insiders.
Analyst Ratings Changes
Check Out Our Latest Analysis on DHR
Danaher Stock Performance
Shares of DHR stock opened at $210.97 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market cap of $149.02 billion, a P/E ratio of 43.50, a P/E/G ratio of 3.28 and a beta of 0.81. The firm’s 50 day moving average price is $203.94 and its 200-day moving average price is $200.14. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were given a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio is 26.39%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- How to Use Stock Screeners to Find Stocks
- Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings
- Pros And Cons Of Monthly Dividend Stocks
- Why Investors Shouldn’t Fear the Dip in Microsoft Stock
- What is Put Option Volume?
- DigitalOcean’s Tide Has Turned: Get Ready to Ride the Wave
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
